CoChat
Sign Up
Cited by 722Protein Structure and DynamicsEnzyme Structure and FunctionMachine Learning in Bioinformatics

The DOI matches its Crossref record; 86 of the 91 references it cites were found in a registry or an index; 4 of the 35 sources its claims cite were checked for support.

A structural biology community assessment of AlphaFold2 applications

Open access
Akdel, Mehmet, Pires, Douglas E. V., Pardo, Eduard Porta, Jänes, Jürgen, Zalevsky, Arthur O., Mészáros, Bálint, Bryant, Patrick, Good, Lydia L., Laskowski, Roman A., Pozzati, Gabriele, Shenoy, Aditi, Zhu, Wensi, Kundrotas, Petras, Serra, Victoria Ruiz, Rodrigues, Carlos H. M., Dunham, Alistair S., Burke, David, Borkakoti, Neera, Velankar, Sameer, Frost, Adam, Basquin, Jérôme, Lindorff-Larsen, Kresten, Bateman, Alex, Kajava, Andrey V., Valencia, Alfonso, Ovchinnikov, Sergey, Durairaj, Janani, Ascher, David B., Thornton, Janet M., Davey, Norman E., Stein, Amelie, Elofsson, Arne, Croll, Tristan I., Beltrao, Pedro·2022·Nature Structural & Molecular Biology
DOI 10.1038/s41594-022-00849-wPMC PMC9663297
Open this paper in CoChat — free accountOpen PDF

Abstract

Most proteins fold into 3D structures that determine how they function and orchestrate the biological processes of the cell. Recent developments in computational methods for protein structure predictions have reached the accuracy of experimentally determined models. Although this has been independently verified, the implementation of these methods across structural-biology applications remains to be tested. Here, we evaluate the use of AlphaFold2 (AF2) predictions in the study of characteristic structural elements; the impact of missense variants; function and ligand binding site predictions; modeling of interactions; and modeling of experimental structural data. For 11 proteomes, an average of 25% additional residues can be confidently modeled when compared with homology modeling, identifying structural features rarely seen in the Protein Data Bank. AF2-based predictions of protein disorder and complexes surpass dedicated tools, and AF2 models can be used across diverse applications equally well compared with experimentally determined structures, when the confidence metrics are critically considered. In summary, we find that these advances are likely to have a transformative impact in structural biology and broader life-science research.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This community assessment evaluates AlphaFold2 (AF2) across structural-biology applications, including proteome coverage, disorder, variant effects, pockets, complexes, and experimental model building. It finds AF2 models are broadly comparable to experimental structures when confidence metrics are critically considered, while low-confidence regions and some high-confidence details still require caution.

Key findings

  • For 11 proteomes shared with the SWISS-MODEL Repository, AF2 added an average of 44% residue coverage; among residues absent from SMR, 49.4% had pLDDT > 70, and on average around 25% of proteome residues were covered by novel, confident AF2 predictions. Across the 11 species, 18,429 contiguous “domain-like” regions (100–500 residues, pLDDT > 70) had no SMR model.
  • AF2-derived disorder metrics (pLDDT and window averages of pLDDT or SASA) outperformed IUPred2. For oligomeric state prediction, 71/87 (82%) top-scoring models matched the correct state; for heterodimeric docking, 31% of AF2 models were correct versus 7% for GRAMM.
  • In variant-effect tests, AF2-based predictions of mutation impact consistently matched or were better than those from experimental models for 117,135 DMS mutations in 33 proteins; stability predictions across 2,648 mutations in 121 proteins were comparable to experimental structures, while homology models degraded below 40% sequence identity.
  • High-quality AF2 pockets (mean pLDDT > 90) performed similarly to pockets from experimental structures, whereas low-confidence pockets generally did not overlap known sites. AF2 also revealed a novel beta-solenoid for pentapeptide repeats, proposed as the shortest repeat length forming such a structure.

Methods

  • The paper is a multi-application benchmark/evaluation study using AF2 predictions from public databases and locally generated models, compared against experimental structures, homology models, SMR, trRosetta/Pfam models, and PDB entries.
  • Datasets included 11 model proteomes, 365,198 AF2 proteins, 104,323 PDB proteins, 117,135 DMS mutations in 33 proteins, 2,648 stability mutations in 121 proteins, 225 proteins with known binding sites, 87 oligomeric proteins, 219 heterodimeric complexes, and 14 IDR-containing complexes.
  • Analyses used structure-based predictors (FoldX, Rosetta, DynaMut2), disorder benchmarking against IUPred2, Geometricus shape-mers with NMF/t-SNE, AutoSite pocket detection, DockQ for docking, and ISOLDE/phenix for cryo-EM and crystallographic model building.

Limitations

  • The paper states that AF2 models can contain uncertainly placed segments, leading to incorrect structural similarity, pocket, variant-effect, or model-building estimates; confidence metrics must be incorporated into workflows. It also notes that even high-confidence regions can contain subtle errors, citing Trp A111 (pLDDT = 86.1) modeled backwards.
  • The authors state that low-confidence predictions are enriched for disorder, but caution this may be partly a by-product of AF2 being trained primarily on X-ray data; they also note IUPred2 is not the best-performing dedicated disorder predictor.
  • The paper states open questions remain about generalization to truly unseen folds, prediction of mutated protein structures, conformational diversity/dynamics, structure without an MSA, and complexes with DNA, RNA, or metabolites. Evident from the text: several benchmarks rely on specific released databases and curated sets, and some oligomer examples may overlap AF2 training even though the authors argue this still tests oligomeric-state prediction.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41594-022-00849-w

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Additional coverage provided by AF2-predicted models. a, Added structural coverage (per-protein, left; per-residue, middle) and per-residue confidence of regions not covered by SMR (right) for 11 species included in both the AF2 and SMR databases. b, Fraction of confident (pLDDT > 70) residues per human AF2 model, binned by r.m.s.d. from the corresponding trRosetta-derived domain-level Pfam model; 3,035 AF2 predicted structures of protein regions matching one of 1,464 different Pfam domain families were compared with the corresponding trRosetta model. c, Median fragment length and median pLDDT score of human AF2-only regions. The highlighted area identifies high-confidence regions with domain-like length. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. d, Comparison of AF2 SASA (SASA20, 20-residue smoothing) and pLDDT (pLDDT20, 20-residue smoothing) against a disorder prediction method (IUpred2).
Fig. 1 Additional coverage provided by AF2-predicted models. a, Added structural coverage (per-protein, left; per-residue, middle) and per-residue confidence of regions not covered by SMR (right) for 11 species included in both the AF2 and SMR databases. b, Fraction of confident (pLDDT > 70) residues per human AF2 model, binned by r.m.s.d. from the corresponding trRosetta-derived domain-level Pfam model; 3,035 AF2 predicted structures of protein regions matching one of 1,464 different Pfam domain families were compared with the corresponding trRosetta model. c, Median fragment length and median pLDDT score of human AF2-only regions. The highlighted area identifies high-confidence regions with domain-like length. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. d, Comparison of AF2 SASA (SASA20, 20-residue smoothing) and pLDDT (pLDDT20, 20-residue smoothing) against a disorder prediction method (IUpred2).CC BY · PubMed Central
Fig. 2 The space of characteristic structural elements in AF2 structural models for 21 species. Visualization of t-SNE dimensionality reduction analysis, in which structures with similar structural elements are placed closer together and the 20 most common superfamilies are colored. The axes corresponding to the t-SNE dimension 1 and t-SNE dimension 2 were omitted. Six shape-mer groups (that is, topics) discussed in the text, consisting of mainly AF2 proteins as opposed to PDB proteins, are labeled A–F, and a representative structure is depicted for each. Residues in the representative structures are colored according to their contribution to the topic under consideration—red residues have the highest contribution, and blue residues are specific to the example and not to the topic.
Fig. 2 The space of characteristic structural elements in AF2 structural models for 21 species. Visualization of t-SNE dimensionality reduction analysis, in which structures with similar structural elements are placed closer together and the 20 most common superfamilies are colored. The axes corresponding to the t-SNE dimension 1 and t-SNE dimension 2 were omitted. Six shape-mer groups (that is, topics) discussed in the text, consisting of mainly AF2 proteins as opposed to PDB proteins, are labeled A–F, and a representative structure is depicted for each. Residues in the representative structures are colored according to their contribution to the topic under consideration—red residues have the highest contribution, and blue residues are specific to the example and not to the topic.CC BY · PubMed Central
Fig. 3 Comparing structure-based prediction of impact of protein missense mutations using experimental and AF2-derived models. a, Relationship between the predicted ΔΔG for mutations with measured experimental impact of the mutation from deep mutational scanning data (−1 × Pearson correlation). The predicted change in stability was determined using one of three structure-based methods, using structures from AF2 or available experimental models. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR (interquartile range). A total of 117,135 mutations were used in the analysis. b, Correlations based on the FoldX predictions as in a, but subsetting the positions in AF2 models according to confidence and whether the position is present in an experimental structure. Data are presented as mean values ± the confidence intervals calculated via fisher’s Z transform (R’s cor.test function). c, The mean impact of a mutation, calculated as the enrichment ratio (ER) score, from DMS data for positions in AF2 models with different degrees of confidence. A total of 117,135 mutations were used in the analysis. d, Comparative performance of methods for predicting stability changes upon mutation using AF2 and experimental and homology models based on protein structure templates of different identity cut-offs. Experimental measurements of stability are for 2,648 single-point missense mutations over 121 proteins. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR. e, Example application for structure-based prediction of stability impact of known disease mutations for a human protein with little structural coverage prior to AF2. ΔΔG stability changes were predicted using Rosetta, and a substantial impact was considered for ΔΔG > 1.5 kcal/mol.
Fig. 3 Comparing structure-based prediction of impact of protein missense mutations using experimental and AF2-derived models. a, Relationship between the predicted ΔΔG for mutations with measured experimental impact of the mutation from deep mutational scanning data (−1 × Pearson correlation). The predicted change in stability was determined using one of three structure-based methods, using structures from AF2 or available experimental models. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR (interquartile range). A total of 117,135 mutations were used in the analysis. b, Correlations based on the FoldX predictions as in a, but subsetting the positions in AF2 models according to confidence and whether the position is present in an experimental structure. Data are presented as mean values ± the confidence intervals calculated via fisher’s Z transform (R’s cor.test function). c, The mean impact of a mutation, calculated as the enrichment ratio (ER) score, from DMS data for positions in AF2 models with different degrees of confidence. A total of 117,135 mutations were used in the analysis. d, Comparative performance of methods for predicting stability changes upon mutation using AF2 and experimental and homology models based on protein structure templates of different identity cut-offs. Experimental measurements of stability are for 2,648 single-point missense mutations over 121 proteins. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR. e, Example application for structure-based prediction of stability impact of known disease mutations for a human protein with little structural coverage prior to AF2. ΔΔG stability changes were predicted using Rosetta, and a substantial impact was considered for ΔΔG > 1.5 kcal/mol.CC BY · PubMed Central
Fig. 4 Pocket detection and function prediction. a, Size of known binding sites (or unified binding sites) compared with the size of top AutoSite pockets in experimental holo (bound), experimental apo (unbound) and AF2 structures. AF2 structures are split into high-confidence (mean pLDDT > 90) and low-confidence (mean pLDDT ≤ 90) subsets. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR. b, Distribution of overlap between known binding sites and top predicted pockets for holo, apo and AF2 structures. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR (interquartile range). c, Enzymatic activity prediction using pocket-derived, template-derived and combined metrics. AUC, area under the curve. TPR, true positive rate; FPR, false positive rate. d, Superposition of the AF2 model of DEGS1 (O15121) with PDB entry 4ZYO. Orange: ribbon representation of AF2 predicted structure for DEGS1. Cyan: ribbon representation of 4ZYO. Zinc atoms (light blue spheres) and bound substrate (dark blue ball and stick) as observed in the structure of 4ZYO are also shown. e, Close up of the metal-binding center of 4ZYO. Ribbon representation of the protein and metal chelators for DEGS1 and 4ZYO are shown in orange and cyan, respectively. The zinc atoms observed in 4ZYO are shown as light blue spheres. Metal-chelating residues for DEGS1 are clearly identifiable.
Fig. 4 Pocket detection and function prediction. a, Size of known binding sites (or unified binding sites) compared with the size of top AutoSite pockets in experimental holo (bound), experimental apo (unbound) and AF2 structures. AF2 structures are split into high-confidence (mean pLDDT > 90) and low-confidence (mean pLDDT ≤ 90) subsets. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR. b, Distribution of overlap between known binding sites and top predicted pockets for holo, apo and AF2 structures. The bottom, middle line and top of the box correspond to the 25th, 50th and 75th percentiles, respectively. The lines extend to 1.5 × IQR (interquartile range). c, Enzymatic activity prediction using pocket-derived, template-derived and combined metrics. AUC, area under the curve. TPR, true positive rate; FPR, false positive rate. d, Superposition of the AF2 model of DEGS1 (O15121) with PDB entry 4ZYO. Orange: ribbon representation of AF2 predicted structure for DEGS1. Cyan: ribbon representation of 4ZYO. Zinc atoms (light blue spheres) and bound substrate (dark blue ball and stick) as observed in the structure of 4ZYO are also shown. e, Close up of the metal-binding center of 4ZYO. Ribbon representation of the protein and metal chelators for DEGS1 and 4ZYO are shown in orange and cyan, respectively. The zinc atoms observed in 4ZYO are shown as light blue spheres. Metal-chelating residues for DEGS1 are clearly identifiable.CC BY · PubMed Central
Fig. 5 Using AF2 to predict homo-oligomeric assemblies and their oligomeric state. a, AF2 prediction for each oligomeric state (1–4 for monomers and dimers, and 1–5 for trimers and tetramers). Only proteins for which the monomer had pLDDT > 90 are shown. For visualization, the predicted successes (top) and failures (bottom) were separated into two plots. Success is defined when the peak of the homo-oligomeric state scan matches the annotation, or the pTMscore of the next oligomer state is substantially lower (−0.1). b, For each of the annotated assemblies, the pTMscore of monomeric prediction is compared with the max pTMscore of non-monomeric prediction. c, Monomer prediction failure. Two monomers were predicted to be homo-dimers. For the first case (PDB: 1BKZ), the prediction matched the asymmetric unit (shown as blue/green and prediction in white). For the second case (PDB: 1BWZ), the prediction matched one of the crystallographic interfaces. d, 3TDT trimer was predicted to be a tetramer. Although the interface is technically correct, for this c-symmetric protein, the pTMscore was not able to discriminate between 3 and 4 copies. e, Comparison of docking quality between AF2 (x axis) and a standard docking tool GRAMM (y axis). Comparisons were made using the DockQ score. Models with a DockQ score that was higher than 0.23 are assumed to be acceptable according to the Critical Assessment for Predicted Interactions (CAPRI) criteria (marked outside the shaded area). Black circles indicate the complex was well modeled by both methods. The average DockQ score and the number of acceptable or better models are shown in the axis labels. It should be noted here that AF2 both folds and docks the proteins, whereas GRAMM only docks them. f, Examples of AF2-predicted interactions mediated by regions of intrinsic disorder.
Fig. 5 Using AF2 to predict homo-oligomeric assemblies and their oligomeric state. a, AF2 prediction for each oligomeric state (1–4 for monomers and dimers, and 1–5 for trimers and tetramers). Only proteins for which the monomer had pLDDT > 90 are shown. For visualization, the predicted successes (top) and failures (bottom) were separated into two plots. Success is defined when the peak of the homo-oligomeric state scan matches the annotation, or the pTMscore of the next oligomer state is substantially lower (−0.1). b, For each of the annotated assemblies, the pTMscore of monomeric prediction is compared with the max pTMscore of non-monomeric prediction. c, Monomer prediction failure. Two monomers were predicted to be homo-dimers. For the first case (PDB: 1BKZ), the prediction matched the asymmetric unit (shown as blue/green and prediction in white). For the second case (PDB: 1BWZ), the prediction matched one of the crystallographic interfaces. d, 3TDT trimer was predicted to be a tetramer. Although the interface is technically correct, for this c-symmetric protein, the pTMscore was not able to discriminate between 3 and 4 copies. e, Comparison of docking quality between AF2 (x axis) and a standard docking tool GRAMM (y axis). Comparisons were made using the DockQ score. Models with a DockQ score that was higher than 0.23 are assumed to be acceptable according to the Critical Assessment for Predicted Interactions (CAPRI) criteria (marked outside the shaded area). Black circles indicate the complex was well modeled by both methods. The average DockQ score and the number of acceptable or better models are shown in the axis labels. It should be noted here that AF2 both folds and docks the proteins, whereas GRAMM only docks them. f, Examples of AF2-predicted interactions mediated by regions of intrinsic disorder.CC BY · PubMed Central
Fig. 6 Application of AF2 predictions to modeling into cryo-EM or crystallographic data. a, AF2 predictions for individual chains in 6O85, aligned to the original model and colored by Cα–Cα distance, with the map (EMD-0651) contoured at 6.5 σ. Red domains at the bottom were correctly folded but misplaced owing to flexibility; smaller regions of red correspond either to flexible tails or register errors in the original model. b,c, Use of adaptive distance and torsion restraints to correct problematic geometry in the original model. The models before (b) and after (c) refitting are shown; satisfied distance restraints are hidden for clarity. d, Owing to very poor local resolution and lack of homologs, the carboxy-terminal domain in chain J (left of the dashed line) was previously left unmodeled. This domain was predicted with high confidence by AF2 (mean pLDDT = 83.0), and fit readily into the available density. e, High-confidence regions may still contain subtle errors that are difficult or impossible to detect in the absence of experimental data. The side chain of Trp A111 (pLDDT = 86.1) was modeled backwards (blue), forming an H-bond with Asp A77; the final model fitted to the map (gray) instead forms an H-bond with Glu A81. f, Rebuilding the recent 3.3-Å crystal structure 7OGG, starting from molecular replacement with AF2 models, dramatically improved model completeness. Blue, residues identified in original model; yellow sticks, residues modeled as unknown in the original model; red, residues identified in rebuilt model. g, Helix modeled as unknown (residues 558–573 of chain R, red), surrounded by unmodeled density (3 σ mFo-DFc, green(+), red(–); +2 σ sharpened 2mFo-DFc, cyan surface; +1.5 σ unsharpened 2mFo-DFc difference map (Fo and Fc are the experimentally measured and model-based amplitudes, D is the Sigma-A weighting factor and m is the figure of merit), cyan wireframe; +5 σ anomalous difference map, purple surface and arrows). h, Final model, with anomalous difference blobs corresponding to selenomethionine residues 213 and 217 of chain Q and with the previously unmodeled density filled; this region was predicted with an average pLDDT of 88, and required only minor side chain corrections to fit the density.
Fig. 6 Application of AF2 predictions to modeling into cryo-EM or crystallographic data. a, AF2 predictions for individual chains in 6O85, aligned to the original model and colored by Cα–Cα distance, with the map (EMD-0651) contoured at 6.5 σ. Red domains at the bottom were correctly folded but misplaced owing to flexibility; smaller regions of red correspond either to flexible tails or register errors in the original model. b,c, Use of adaptive distance and torsion restraints to correct problematic geometry in the original model. The models before (b) and after (c) refitting are shown; satisfied distance restraints are hidden for clarity. d, Owing to very poor local resolution and lack of homologs, the carboxy-terminal domain in chain J (left of the dashed line) was previously left unmodeled. This domain was predicted with high confidence by AF2 (mean pLDDT = 83.0), and fit readily into the available density. e, High-confidence regions may still contain subtle errors that are difficult or impossible to detect in the absence of experimental data. The side chain of Trp A111 (pLDDT = 86.1) was modeled backwards (blue), forming an H-bond with Asp A77; the final model fitted to the map (gray) instead forms an H-bond with Glu A81. f, Rebuilding the recent 3.3-Å crystal structure 7OGG, starting from molecular replacement with AF2 models, dramatically improved model completeness. Blue, residues identified in original model; yellow sticks, residues modeled as unknown in the original model; red, residues identified in rebuilt model. g, Helix modeled as unknown (residues 558–573 of chain R, red), surrounded by unmodeled density (3 σ mFo-DFc, green(+), red(–); +2 σ sharpened 2mFo-DFc, cyan surface; +1.5 σ unsharpened 2mFo-DFc difference map (Fo and Fc are the experimentally measured and model-based amplitudes, D is the Sigma-A weighting factor and m is the figure of merit), cyan wireframe; +5 σ anomalous difference map, purple surface and arrows). h, Final model, with anomalous difference blobs corresponding to selenomethionine residues 213 and 217 of chain Q and with the previously unmodeled density filled; this region was predicted with an average pLDDT of 88, and required only minor side chain corrections to fit the density.CC BY · PubMed Central

Verification

Claims the paper makes

50 Own result · 24 Own interpretation · 23 Not checked yet · 15 No basis given · 2 Supported · 1 Partly supported · 1 Own method · accuracy not yet measured

Verify all 31 references — free account

Show all 69 claims

  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 34
  • The quote only partly states this claim. 2
47 of 47

  • The paper relies on this without support.

    The implementation of computational protein structure prediction methods across structural-biology applications remains to be tested.

    “Although this has been independently verified, the implementation of these methods across structural-biology applications remains to be tested.”

  • The paper relies on this without support.

    Many questions remain regarding the extent to which AF2 approaches extend coverage of structural biology and the limitations of AF2 for applications in biology.

    “Yet many questions remain regarding the extent to which these approaches extend our coverage of structural biology, and the limitations of the AF2 method or structures derived from AF2 for applications in biology.”

  • The paper relies on this without support.

    A protein structure facilitates the generation of hypotheses regarding the impact of missense mutations.

    “A protein structure facilitates the generation of hypotheses regarding the impact of missense mutations.”

  • The paper relies on this without support.

    An agreement between the expected and observed impacts of mutations provides confidence in the accuracy of a structural model.

    “Conversely, an agreement between the expected and observed impacts of mutations provides confidence in the accuracy of a structural model.”

  • The paper relies on this without support.

    AF2 is trained primarily on X-ray data.

    “As AF2 is trained primarily on X-ray data, the relation between disorder and predicted confidence could be a by-product of using this definition of disorder.”

  • The paper relies on this without support.

    Protein disordered regions are often defined as regions that are not solved by X-ray crystallography.

    “However, we note that the protein disordered regions are often defined as regions that are not solved by X-ray crystallography.”

  • The paper relies on this without support.

    Many LBSp structures are from species not included in the public AlphaFold database.

    “In the latter case, we used locally modeled structures, as many LBSp structures are from species not included in the public database.”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Mirdita, M. et al. ColabFold—making protein folding accessible to all. Nat. Methods 19, 679–682 (2022). · DOI · Paper page

Cited by

Sorted by citations

Items 701–722 of 722

Related

See all

Metadata

Authors
Akdel, M., Pires, D. E. V., Pardo, E. P., Jänes, J., Zalevsky, A. O., Mészáros, B., Bryant, P., Good, L. L., Laskowski, R. A., Pozzati, G., Shenoy, A., Zhu, W., Kundrotas, P., Serra, V. R., Rodrigues, C. H. M., Dunham, A. S., Burke, D., Borkakoti, N., Velankar, S., Frost, A., Basquin, J., Lindorff-Larsen, K., Bateman, A., Kajava, A. V., Valencia, A., Ovchinnikov, S., Durairaj, J., Ascher, D. B., Thornton, J. M., Davey, N. E., Stein, A., Elofsson, A., Croll, T. I., & Beltrao, P.
Affiliations
  • Wageningen University & Research (NL)
  • The University of Melbourne (AU)
  • European Bioinformatics Institute (GB)
  • Russian Academy of Sciences (RU)
  • European Molecular Biology Laboratory (DE)
  • Science for Life Laboratory (SE)
  • University of Copenhagen (DK)
  • University of California, San Francisco (US)
  • Max Planck Institute of Biochemistry (DE)
  • Centre National de la Recherche Scientifique (FR)
  • Barcelona Supercomputing Center (ES)
  • Harvard University (US)
  • University of Basel (CH)
  • The University of Queensland (AU)
  • Institute of Cancer Research (GB)
  • University of Cambridge (GB)
Corresponding author
  • Valencia, Alfonso
  • Ovchinnikov, Sergey
  • Durairaj, Janani
  • Ascher, David B.
  • Thornton, Janet M.
  • Davey, Norman E.
  • Stein, Amelie
  • Elofsson, Arne
  • Croll, Tristan I.
ORCID
Venue
Nature Structural & Molecular Biology
Publisher
Springer Science and Business Media LLC
Published
2022-11
Volume
29
Issue
11
Pages
1056-1067
ISSN
  • 1545-9985 (ISSN-L)
  • 1545-9993
DOI
10.1038/s41594-022-00849-w
PMC
PMC9663297
OpenAlex
W4308463927
Semantic Scholar
7bde0455b85732e9853f17f6b671c1e91884af78
Cited by
675
References
91
Citations by year
2026: 137 · 2025: 143 · 2024: 171 · 2023: 174 · 2022: 47
FWCI
44.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Structural & Molecular Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • edoc (University of Basel) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Socio-Environmental Systems Modeling (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • National Science Foundation (2032259)
  • Simons Foundation (735929LPI)
  • Wellcome Trust
  • Swedish e-Science Research Centre
  • Cancer Research UK (28159)
  • European Commission (HORIZON2020, 842490)
  • Eidgenössische Technische Hochschule Zürich
  • Lundbeckfonden (R272-2017-4528)
  • Novo Nordisk
  • Vetenskapsrådet (2016-06301, Berzelius-2021-29)
  • State Government of Victoria
  • Russian Science Foundation (20-14-00121)
  • Novo Nordisk Fonden (NNF18OC0033950)
  • ETH Zürich Foundation
  • H. Lundbeck A/S
  • Helmut Horten Stiftung
  • National Institutes of Health (RYC2019-026415-I, DP5OD026389)
  • Medical Research Council
  • National Health and Medical Research Council (1174405)
  • National Institute of Allergy and Infectious Diseases (R21AI156595)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
Keywords
AlphaFold2, protein structure prediction, protein disorder prediction, protein complex modeling, ligand binding site prediction, confidence measures, Protein Data Bank
MeSH terms
Binding Sites, Furylfuramide, Protein Conformation, Proteins, Computational Biology, Databases, Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review